The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years
{{output}}
Background: Immunotherapy, remarkably immune checkpoint inhibitors, has shown significant efficacy and survival benefits in patients with various solid tumors. Although T lymphocytes have been extensively studied as the primary t... ...
